温肾利水法联合前列地尔治疗肝硬化并发肝肾综合征29例

肖倩; 张旸; 谭善忠

温肾利水法联合前列地尔治疗肝硬化并发肝肾综合征29例

东南大学附属南京市第二医院中西医结合科

基金项目:

南京市医学科技发展资金(青年卫生人才培养工程)；江苏省中医药领军人才(LJ200922)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 3242
- HTML全文浏览量: 15
- PDF下载量: 718
- 被引次数: 0
出版历程
- 出版日期: 2012-03-20

The treatment by warming the kidney and promoting diuresis with Alprostadil in liver cirrhosis complicated with hepato-renal syndrome in 29 cases

Research funding:

摘要

摘要: 目的观察温肾利水法联合前列地尔对肝硬化并发肝肾综合征患者肝、肾功能及尿量的影响。方法将57例肝硬化并发肝肾综合征患者随机分为治疗组和对照组。对照组28例,常规予限钠、支持、保肝、利尿、补充白蛋白、抗感染、应用血管扩张剂及促肝细胞生长素等对症治疗,前列地尔10μg静脉滴注。治疗组29例在对照组治疗基础上予自拟温肾利水中药汤剂口服。两组均以三周为一疗程。1疗程后观察比较两组治疗前后临床症状、腹水、肝肾功能及尿量变化。结果临床疗效比较,治疗组总有效率86.21%,对照组总有效率67.86%。两组总有效率比较差异有统计学意义(P<0.05)。结论温肾利水法联合前列地尔在肝硬化并发肝肾综合征的治疗上能更好地改善临床症状,缩短腹水消退时间,改善肝、肾功能,延缓和阻止病情的进展。
- 肝硬化 /
- 肝肾综合征 /
- 温肾利湿 /
- 前列地尔
Abstract: Objective To observe the influence of treatment in patients' urine volume, liver and renal function by warming the Kidney and promoting diuresis with Alprostadil in patients with liver cirrhosis complicated with hepato-renal syndrome.Methods 57 patients with liver cirrhosis complicated with hepato-renal syndrome were randomly divided into the treatment group and control group.The control group of 28 cases was treated with the conventional therapyby limiting the sodium intake, supporting, protecting the liver, diuresis, adding albumin, antibiotics, applying vasodilator agents and hepatocyte growth-promoting factors and symptomatic treatmentby intravenous infusion of Alprostadil 10 μg.The treatment group was treated with the conventional therapy with oral decoction by warming the kidney and promoting diuresis.The course of treatment was 3 weeks in both the groups.After 1 treatment course, observe the change of the clinical symptoms, ascites, the liver and renal function and urine volume.Results Clinical curative effect was compared.The effective rate was 86.21% in the treatment group and 67.86% the control group.The difference was statistically significant (P< 0.05) .Conclusion The treatment by warming the kidney and promoting diuresis with Alprostadil in liver cirrhosis complicated with hepato-renal syndrome can improve the clinical symptoms, reduce the ascites subsiding time, improve the liver and renal function, delay and stop the progress of the disease.
- liver cirrhosis /
- hepatorenal syndrome /
- WARMING KIDNEY PROMOT DIURESIS /
- alprostadil

HTML全文

参考文献(5)

[1]Ginès A, Escorsell A, Ginès P, et al.Incidence, predictive fac-tors, and prognosis of the hepatorenal syndrome in cirrhosiswith ascites[J].Gastroenterology, 1993, 105 (1) :229-236.

[2]中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329.

[3]中国中西医结合学会消化系统疾病专业委员会.肝硬化中西医结合诊治方案[J].现代消化及介入诊疗杂志, 2005, 10 (2) :119-121.

[4]Arroyo V, Ginès P, Gerbes AL, et al.Definition and diagnos-tic criteria of refractory ascites and hepatorenal syndrome incirrhosis.International Ascites Club[J].Herpetology, 1996, 23 (1) :164-176.

[5]童巧霞, 蔡淑清.前列地尔治疗重型肝炎及肝炎肝硬化合并肝肾综合征的临床观察[J].中西医结合肝病杂志, 2003, 13 (1) :13-14.

施引文献

资源附件(0)

访问统计